Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.
A specially trained algorithm could aid the search for biological activity both on the early Earth and on other worlds.
Citations and placement in AI answers are turning into the visibility signals that decide who enters the final click.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback